Danaher (NYSE:DHR) said that Matthew Gugino, the current group CFO of the company’s Life Sciences Innovations Group and VP of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher’s CFO effective February 28, 2026.
Mr. McGrew has served as Danaher’s CFO since January 2019 and will continue as an executive VP of the company as he begins a gradual transition to retirement after more than 20 years with Danaher.
Mr. Gugino joined Danaher in 2013 and has served as Group CFO in the company’s Life Sciences Innovations Group since 2021.
